Getty Images has announced what it says is the industry's first model release that reflects advancements in data privacy and security as well as covering artificial intelligence, machine learning, and biometric data security.
Smarterpix, Germany's leading stock photo agency, has announced an industry-first: a set of stock portraits that are 100% generated by artificial intelligence (AI) and available for legal licensing.
B.J. Novak is best known for acting in, writing, directing, and producing the hit TV show The Office. Over the past several years, however, his face has also appeared in all kinds of products around the world... completely without his knowledge or permission.
Like chameleons, we photographers change with our environment to survive and thrive. It's inspiring to see the way we have risen to new and ever-evolving challenges in the industry. Yet, photographers are being taken advantage of now more than ever.
Recently, the creators behind Mango Street shared how their stock photos made them $47,000 in one year, but how realistic is this scenario for other photographers to emulate?
Shutterstock has announced the acquisition of PicMonkey, an online photo editing and design platform, for $110 million.
After over half a century as a privately-held business, the Swedish lighting company Profoto went public today, listing its shares on the Nasdaq Stockholm stock exchange. As a public company, Profoto is now required to publicly disclose its financial performance for the first time.
It was so close to the first of April, it sounded like an April’s fool hoax: the gentle freedom-loving all sharing company would be selling to the greedy capitalistic money-making titan. Or, in other words, Getty Images was acquiring Unsplash. The two unlikely partners officially became at the end of April, sending ripples through the stock photography world and beyond.
Unsplash has announced that as of today it is being acquired by Getty Images. In a blog post, Unsplash's founder Mikael Cho says that it will continue to operate as a standalone brand inside of Getty and that the free content model won't be changing.
Shooting timelapse is certainly a lot of fun, but trying to sell them and make money is an entirely separate story. So that leads to the question: how can you monetize the planning, time spent shooting, and the effort of editing hundreds or thousands of pictures into extra income or maybe a new career?
Kodak's stock price has gone on quite a roller coaster ride over the past week after the company announced a $765M US loan to pivot into generic drug production. But it's not just the price people are talking about -- unusual trading activity and a stock option grant to Kodak's CEO are also making headlines.
If you were an investor in Kodak prior to this week, you're probably grinning from ear to ear right now. After news emerged yesterday that Kodak is doing a major pivot into drug manufacturing with a $765M loan from the US government, mom-and-pop investors are now piling into KODK, sending the stock soaring over 2,000%.
Kodak's stock skyrocketed severalfold today, and it had nothing to do with the company's long-established business in the world of photography. News broke that Kodak had secured at $765 million loan from the US government to shift its attention to producing ingredients for generic drugs.
For those who are anywhere near the microstock photography industry, you may have noticed that there is a lot of shouting going on at the moment about the latest release from Shutterstock.
On June 1st, Shutterstock unveiled a new royalty structure that infuriated photographers, sparked widespread criticism, and even inspired an online petition with over 7,500 signatures. On that same day, Dreamstime increased royalties by 10% to support their contributors during this difficult time.
Activist investor Daniel Loeb is reportedly using the current low stock prices to build a bigger stake in Sony and "push for changes," including spinning off the brand's image sensor business into a separate entity called Sony Technologies.
It is very hard to find any positives in the virus that is sweeping the world and creating havoc with every economy. But one thing that is happening in our stock world is that images and videos are being sought by buyers that just never existed before.
Canon USA has jumped into the battle against the novel coronavirus, announcing that the company's medical division (Canon Medical Systems Corporation) has started "development of a rapid genetic testing system for the novel coronavirus."
Fujifilm's stock soared on Tuesday after Chinese health officials declared that an antiviral drug the company developed in 2014 is safe and "clearly effective" in fighting COVID-19, the disease caused by the novel coronavirus.
An elderly English couple took to the papers last week to share the unfortunate story of how they were tricked into hiring an amateur photographer for their wedding, alleging that the unnamed photographer was passing off stock photography as their own on their social media pages.